Blog

Pancreatic cancer remains one of the most formidable challenges in oncology, characterized by a dismal five-year survival rate hovering around 13 percent. This high mortality rate is largely attributed to the cancer’s notorious resistance to conventional therapies and its highly complex tumor microenvironment. Recent research

In a groundbreaking advancement that could redefine how aggressive brain cancers are monitored, researchers at the Mayo Clinic in Rochester, Minnesota, have unveiled a promising method to track the progression of high-grade gliomas using a personalized blood test. These tumors, notorious for their rapid growth

In the relentless pursuit to combat breast cancer, a disease notorious for its complexity and adaptive resistance to conventional treatments, researchers are turning their gaze to a novel contender: cannabidiol (CBD). Derived from the Cannabis sativa plant, CBD is a non-psychoactive compound that has recently

In the rapidly evolving landscape of cancer research, a groundbreaking study from the Max Delbrück Center for Molecular Medicine (MDC) is redefining how we understand the tumor microenvironment. Led by Professor Nikolaus Rajewsky and his team at the Berlin Institute for Medical Systems Biology, this

In a pioneering advancement at the intersection of oncology and artificial intelligence, researchers from the ECOG-ACRIN Cancer Research Group have harnessed cutting-edge AI-driven methodologies to detect tertiary lymphoid structures (TLS) within thousands of high-resolution digital melanoma tumor images. This breakthrough significantly refines the identification of

In a groundbreaking study recently published in BMC Cancer, researchers have unveiled significant abnormalities in the proportions and functional dynamics of myeloid-derived suppressor cells (MDSCs) in the peripheral blood of patients suffering from diffuse large B-cell lymphoma (DLBCL). These findings shed new light on the

In a groundbreaking advancement bridging artificial intelligence and personalized oncology, researchers from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) have successfully demonstrated an AI-driven platform capable of optimizing chemotherapy dosing for patients with advanced solid tumors. This

Breast cancer remains one of the most challenging diseases in oncology, in part due to its capacity for late recurrence. Despite advances in therapy that have turned many diagnoses into manageable or even curable conditions, some breast cancer cells have the insidious ability to lie

In a groundbreaking advancement that bridges the worlds of imaging technology and neurobiology, researchers at UC Davis Health have unveiled a revolutionary method for quantitatively assessing the blood-brain barrier (BBB) using their cutting-edge total body PET scanner, EXPLORER. This breakthrough paves the way for earlier

Hepatocellular carcinoma (HCC) remains one of the most formidable challenges in oncology, notably within Egypt—the nation where it is the leading cause of cancer morbidity and mortality—and globally. Despite advances in imaging and therapeutic interventions, the quest for reliable, non-invasive biomarkers that can enhance early